Privia Health Group, Inc. (PRVA) P/E Ratio History
UndervaluedTrading at 112.8x vs 5Y avg 150.9x · 14th percentile · Below historical baseline · Data 2023–2026
Loading P/E history...
P/E Ratio Analysis
As of October 3, 2026, Privia Health Group, Inc. (PRVA) trades at a price-to-earnings ratio of 112.8x, with a stock price of $20.30 and trailing twelve-month earnings per share of $0.21.
The current P/E is 25% below its 5-year average of 150.9x. Over the past five years, PRVA's P/E has ranged from a low of 74.2x to a high of 255.4x, placing the current valuation at the 14th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.2x, PRVA trades at a 387% premium to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.0x.
Relative to the broader market, PRVA commands a significant premium over the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PRVA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PRVA Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
PRVA P/E vs Peers
Care Delivery Networks and Value-Based Care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 28.5 | 0.55Best | -12% | |
| $164B | 163.9 | - | -11% | |
| $338B | 28.1Lowest | - | -15% | |
| $110B | 62.2 | - | -62% | |
| $47B | 39.5 | - | -1% | |
| $44B | 50.2 | 2.76 | +26%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
PRVA Historical P/E Data (2023–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $25.73 | $0.22 | 118.6x | -21% |
| FY2026 Q1 | - | $20.57 | $0.17 | 122.6x | -19% |
| FY2025 Q4 | Dec 31 2025 | $23.71 | $0.17 | 136.0x | -10% |
| FY2025 Q3 | - | $24.90 | $0.14 | 179.1x | +19% |
| FY2025 Q2 | Jun 30 2025 | $23.00 | $0.12 | 198.8x | +32% |
| FY2025 Q1 | Mar 31 2025 | $22.45 | $0.12 | 179.9x | +19% |
| FY2024 Q4 | - | $19.55 | $0.11 | 170.3x | +13% |
| FY2024 Q3 | Sep 30 2024 | $18.21 | $0.10 | 182.1x | +21% |
| FY2024 Q2 | Jun 30 2024 | $17.38 | $0.12 | 144.8x | -4% |
| FY2024 Q1 | Mar 31 2024 | $19.59 | $0.15 | 130.6x | -13% |
| FY2023 Q4 | Dec 31 2023 | $23.03 | $0.19 | 121.2x | -20% |
| FY2023 Q3 | Sep 30 2023 | $23.00 | $0.31 | 74.2x | -51% |
| FY2023 Q2 | Jun 30 2023 | $26.11 | $0.26 | 98.7x | -35% |
| FY2023 Q1 | Mar 31 2023 | $27.61 | $0.11 | 255.4x | +69% |
Average P/E for displayed period: 150.9x
PRVA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRVA — Frequently Asked Questions
Quick answers to the most common questions about buying PRVA stock.
What is PRVA's P/E ratio?
Privia Health Group, Inc. (PRVA) trailing twelve-month P/E ratio is 112.8x, based on TTM diluted EPS of $0.21. The 5-year average P/E is 150.9x and the historical range spans 74.2x to 255.4x.
Is PRVA stock overvalued or undervalued?
PRVA trades at 112.8x P/E, below its 5-year average of 150.9x. At the 14th percentile of its historical range (74.2x–255.4x), the stock is priced at a discount to its own history.
Is PRVA stock expensive?
No, PRVA is not expensive on a historical basis. The current P/E of 112.8x is below the 5-year average of 150.9x and sits at the 14th percentile of its valuation range.
What is PRVA's historical P/E range?
Over the past 5 years, PRVA's P/E ratio has ranged from 74.2x to 255.4x, with a median of 144.8x and an average of 150.9x. The current P/E of 112.8x places the stock at the 14th percentile of this range. Full historical data spans 2023–2026.
How does PRVA's P/E compare to the S&P 500?
PRVA trades at 112.8x P/E versus the S&P 500 median of 24.5x. The 360% premium to the market typically reflects higher expected earnings growth or quality.
How does PRVA's valuation compare to Healthcare peers?
Privia Health Group, Inc. P/E of 112.8x compares to the Healthcare sector median of 23.2x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is PRVA's PEG ratio?
PRVA PEG ratio is N/A, based on a P/E of 112.8x and EPS growth of 63.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is PRVA's earnings yield?
PRVA earnings yield is 0.89%, the inverse of its 112.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.